{"id":72865,"date":"2020-09-23T08:18:22","date_gmt":"2020-09-23T07:18:22","guid":{"rendered":"https:\/\/brandspurng.com\/?p=72865"},"modified":"2020-09-23T08:18:22","modified_gmt":"2020-09-23T07:18:22","slug":"sanofi-and-gsk-sign-agreements-with-the-government-of-canada-to-supply-up-to-72-million-doses-of-adjuvanted-covid-19-vaccine","status":"publish","type":"post","link":"https:\/\/brandspurng.com\/2020\/09\/23\/sanofi-and-gsk-sign-agreements-with-the-government-of-canada-to-supply-up-to-72-million-doses-of-adjuvanted-covid-19-vaccine\/","title":{"rendered":"Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine"},"content":{"rendered":"
<\/div>

Sanofi and GSK have today signed agreements with the Government of Canada for the supply of up to 72 million doses of an adjuvanted COVID-19 vaccine<\/a>, beginning in 2021.<\/span><\/span><\/strong><\/h4>\n
\"Sanofi
Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine – www.brandspurng.com<\/figcaption><\/figure>\n

\u201cToday\u2019s announcement showcases our unwavering commitment to develop a COVID-19 vaccine that is available to everyone when it comes to market,\u201d<\/i>\u00a0said Thomas Triomphe, Executive Vice President and Global Head of Sanofi Pasteur.<\/strong>\u00a0<\/span><\/span><\/p>\n

\u201cTo address a global health crisis of this magnitude, it takes partnerships and we are grateful to Canada for its collaboration, and to GSK for partnering with us to develop a safe and effective vaccine.\u201d<\/i><\/span><\/span><\/p>\n

Roger Connor, President of GSK Vaccines added<\/strong>,\u00a0“GSK is proud to be working in partnership with Sanofi to make this vaccine available as soon as possible in Canada. Both companies have significant R&D and manufacturing capability world-wide and are already working hard to scale up production. This announcement from the Government of Canada supports our ongoing efforts.\u201d<\/i><\/span><\/span><\/p>\n

\u00a0<\/span>Both companies have vaccine manufacturing sites in Canada that are contributing to overall global COVID-19 vaccine development, and these plus their global industrial network will play a pivotal role to the production of the COVID-19 vaccine doses for Canada \u2013 as agreed today.<\/span><\/span>\u00a0<\/span><\/p>\n

The Companies\u00a0initiated<\/u><\/a><\/span>\u00a0a Phase 1\/2 study on September 3 with a total of 440 subjects being enrolled, and anticipate first results in early December 2020, to support the initiation of a pivotal Phase 3 study before the end of the year. If these data are sufficient for licensure application, it is planned to request regulatory approval in the first half of 2021. In parallel, Sanofi and GSK are scaling up manufacturing of the antigen and adjuvant respectively with the target of producing up to one billion doses in total per year, globally.\u00a0\u00a0<\/span><\/span><\/p>\n

\u00a0Sanofi and GSK are committed to making the vaccine available globally<\/span><\/b><\/span><\/span><\/h5>\n

\u00a0<\/span><\/span>On September 18, Sanofi and GSK\u00a0<\/span>signed<\/u><\/a><\/span>\u00a0a final agreement with the European Commission to supply European countries with up to 300 million doses from their European industrial network.In July 2020, Sanofi and GSK\u00a0<\/span>announced<\/u><\/a><\/span>\u00a0a collaborative effort with the U.S. government to supply up to 100 million doses of their COVID-19 recombinant protein-based vaccine to meet the U.S. government\u2019s Operation Warp Speed goal of making hundreds of millions of doses of safe and effective COVID-19 vaccines available in the United States as quickly as possible. <\/span><\/span><\/span><\/p>\n

The U.S. government has a further option to discuss the purchase of up to 500 million doses longer term. Both companies also\u00a0<\/span>agreed<\/u><\/a><\/span>\u00a0(subject to final contract)<\/span>\u00a0with the UK government to supply up to 60 million doses of recombinant protein-based COVID-19 vaccine.<\/span><\/span><\/span><\/p>\n

\u00a0<\/span><\/span>The partners\u00a0<\/span>plan to supply a significant portion of total worldwide available supply to the global initiative\u00a0<\/span>\u201cAccess to COVID\u201019 Tools (ACT) Accelerator\u201d,\u00a0a global collaboration of leaders of governments, global health organizations, businesses and philanthropies to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines.<\/span><\/span><\/span><\/p>\n

\u00a0<\/span>On the front lines in the fight against COVID-19<\/span><\/b><\/span><\/span><\/h5>\n

In addition to the recombinant protein-based vaccine in collaboration with GSK, Sanofi is developing a messenger RNA vaccine in partnership with Translate Bio. With several innovative vaccine platforms currently being investigated across the industry, mRNA is considered among the most promising. Preclinical data shows that two immunizations of the mRNA vaccine induced high neutralizing antibody levels that are comparable to the upper range of those observed in infected humans. Sanofi expects the Phase 1\/2 study to start in November, with earliest potential approval in the second half of 2021. Translate Bio has established mRNA manufacturing capacity and Sanofi expects to be able to supply annual capacity of 90 to 360 million doses.<\/span><\/span><\/span><\/p>\n

HEADLINES YOU MIGHT HAVE MISSED FROM BRAND SPUR<\/a><\/strong><\/em><\/p><\/blockquote>\n

Lagos Business School Beta Gamma Sigma chapter earns Highest Honours status<\/a><\/strong><\/p>\n

The\u00a0Lagos Business School\u00a0chapter of the Beta Gamma Sigma society has been bestowed the Highest Honours status for the 2019-2020 academic year. The Highest Honours status is the highest distinction possible\u00a0for Beta Gamma Sigma chapters.<\/p>\n

Nestl\u00e9 to plant 3 million trees by 2023 in Malaysia<\/a><\/strong><\/p>\n

Nestl\u00e9\u00a0today announced it will plant three million trees through Project RELeaf in Malaysia.\u00a0Nestl\u00e9\u00a0will invest\u00a0CHF<\/acronym>\u00a04 million in the next three years. This announcement is part of Nestl\u00e9\u2019s broader reforestation initiative. It will help accelerate the company\u2019s global pledge to address climate change and achieve zero net greenhouse gas emissions by 2050.<\/p>\n

Nestl\u00e9 S.A. Increases Stake in Nigeria Subsidiary<\/a><\/strong><\/p>\n

Nestl\u00e9 S.A, Switzerland, the parent company of Nestl\u00e9 Nigeria Plc, has increased its ownership percentage of the Nigerian subsidiary to 66.30 per cent.<\/p>\n

Waltersmith Refinery Ready for October Start<\/a><\/strong><\/p>\n

Waltersmith Petroman\u2019s modular refinery\u00a0has been completed and will begin operations on October 14, the\u00a0Nigerian Content Development and Monitoring Board (NCDMB)\u00a0has said.<\/p>\n

How TikTok Changed Video Advertising Forever?<\/a><\/strong><\/p>\n

Owning a business brand isn\u2019t all required to make it big in the business world \u2013 it\u2019s just the first step. To achieve business growth, you\u2019d have to invest in activities that improve the quality of your products and services and make potential buyers aware that you have what they need.<\/p>\n","protected":false},"excerpt":{"rendered":"

Sanofi and GSK have today signed agreements with the Government of Canada for the supply of up to 72 million doses of an adjuvanted COVID-19 vaccine, beginning in 2021. \u201cToday\u2019s announcement showcases our unwavering commitment to develop a COVID-19 vaccine that is available to everyone when it comes to market,\u201d\u00a0said Thomas Triomphe, Executive Vice President […]<\/p>\n","protected":false},"author":3,"featured_media":72866,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_newsletter_tier_id":0,"jetpack_publicize_message":"","jetpack_is_tweetstorm":false,"jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false}}},"categories":[15198,5],"tags":[26063],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/09\/Sanofi-and-GSK-sign-agreements-with-the-Government-of-Canada-to-supply-up-to-72-million-doses-of-adjuvanted-COVID-19-vaccine-Brandspurng.jpg?fit=1880%2C1250&ssl=1","jetpack_shortlink":"https:\/\/wp.me\/p8rAyM-iXf","jetpack-related-posts":[{"id":70926,"url":"https:\/\/brandspurng.com\/2020\/09\/03\/sanofi-and-gsk-initiate-phase-1-2-clinical-trial-of-covid-19-adjuvanted-recombinant-protein-based-vaccine-candidate\/","url_meta":{"origin":72865,"position":0},"title":"Sanofi and GSK initiate Phase 1\/2 clinical trial of COVID-19 adjuvanted recombinant protein-based vaccine candidate","author":"Esan Bolaji","date":"September 3, 2020","format":false,"excerpt":"Sanofi and GSK today started the Phase 1\/2 clinical trial for their adjuvanted COVID-19 vaccine. The vaccine candidate, developed in partnership by Sanofi and GSK, uses the same recombinant protein-based technology as one of Sanofi\u2019s seasonal influenza vaccines with GSK\u2019s established pandemic adjuvant technology. The Phase 1\/2 clinical trial is\u2026","rel":"","context":"In "Brand News"","block_context":{"text":"Brand News","link":"https:\/\/brandspurng.com\/category\/brand-news\/"},"img":{"alt_text":"COVID-19 vaccine, vaccine, Sanofi , GSK, clinical trial of COVID-19 vaccine","src":"https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/09\/Vaccine.jpg?fit=400%2C320&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":90695,"url":"https:\/\/brandspurng.com\/2021\/05\/17\/sanofi-and-gsk-covid-19-vaccine-candidate-demonstrates-strong-immune-responses-across-all-adult-age-groups\/","url_meta":{"origin":72865,"position":1},"title":"Sanofi and GSK COVID-19 vaccine candidate demonstrates strong immune responses across all adult age groups","author":"Esan Bolaji","date":"May 17, 2021","format":false,"excerpt":"May\u00a017,\u00a02021\u00a0\u2013\u00a0The Sanofi and GSK adjuvanted recombinant COVID-19 vaccine candidate\u00a0achieved\u00a0strong\u00a0rates of\u00a0neutralizing antibody responses, in line with\u00a0those measured in people who have recovered from COVID-19,\u00a0in all adult age groups in a Phase 2 study\u00a0with 722\u00a0volunteers. A global pivotal Phase 3 study is expected to start in\u00a0the coming weeks. The Phase 2 interim\u2026","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/brandspurng.com\/category\/health\/"},"img":{"alt_text":"African Countries Look Beyond West for Vaccines brandspurng","src":"https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2021\/02\/African-Countries-Look-Beyond-West-for-Vaccines-brandspurng.jpg?fit=1200%2C800&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2021\/02\/African-Countries-Look-Beyond-West-for-Vaccines-brandspurng.jpg?fit=1200%2C800&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2021\/02\/African-Countries-Look-Beyond-West-for-Vaccines-brandspurng.jpg?fit=1200%2C800&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2021\/02\/African-Countries-Look-Beyond-West-for-Vaccines-brandspurng.jpg?fit=1200%2C800&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2021\/02\/African-Countries-Look-Beyond-West-for-Vaccines-brandspurng.jpg?fit=1200%2C800&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":63238,"url":"https:\/\/brandspurng.com\/2020\/04\/15\/sanofi-and-gsk-to-join-forces-in-unprecedented-caccine-collaboration-to-fight-covid-19\/","url_meta":{"origin":72865,"position":2},"title":"Sanofi And GSK To Join Forces In Unprecedented Caccine Collaboration To Fight COVID-19","author":"Brand Spur","date":"April 15, 2020","format":false,"excerpt":"Sanofi and GSK today announce that they have signed a letter of intent to develop an adjuvanted vaccine for COVID-19, using innovative technology from both companies, to help address the ongoing pandemic.\u00a0 Sanofi will contribute its S-protein COVID-19 antigen, which is based on recombinant DNA technology. This technology has produced\u2026","rel":"","context":"In "Brand News"","block_context":{"text":"Brand News","link":"https:\/\/brandspurng.com\/category\/brand-news\/"},"img":{"alt_text":"Sanofi delivers strong 2019 business EPS growth of 6.8% at CER Brandspurng","src":"https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/02\/Sanofi-delivers-strong-2019-business-EPS-growth-of-6.8-at-CER-Brandspurng.jpg?fit=1200%2C798&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/02\/Sanofi-delivers-strong-2019-business-EPS-growth-of-6.8-at-CER-Brandspurng.jpg?fit=1200%2C798&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/02\/Sanofi-delivers-strong-2019-business-EPS-growth-of-6.8-at-CER-Brandspurng.jpg?fit=1200%2C798&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/02\/Sanofi-delivers-strong-2019-business-EPS-growth-of-6.8-at-CER-Brandspurng.jpg?fit=1200%2C798&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/02\/Sanofi-delivers-strong-2019-business-EPS-growth-of-6.8-at-CER-Brandspurng.jpg?fit=1200%2C798&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":80841,"url":"https:\/\/brandspurng.com\/2020\/12\/11\/sanofi-and-gsk-suffers-major-setback-in-the-development-of-a-covid-19-vaccine\/","url_meta":{"origin":72865,"position":3},"title":"Sanofi and GSK suffers major setback in the development of a Covid-19 vaccine","author":"Esan Bolaji","date":"December 11, 2020","format":false,"excerpt":"December 11, 2020\u00a0\u2013 Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine program to improve immune response in older adults. Phase 1\/2 study interim results showed an immune response comparable to patients who recovered from COVID-19 in adults aged 18 to 49 years, but a low\u2026","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/brandspurng.com\/category\/health\/"},"img":{"alt_text":"Sanofi and GSK suffers major setback in the development of a Covid-19 vaccine bRANDSPURNG","src":"https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/12\/Sanofi-and-GSK-suffers-major-setback-in-the-development-of-a-Covid-19-vaccine-bRANDSPURNG.png?fit=1024%2C576&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/12\/Sanofi-and-GSK-suffers-major-setback-in-the-development-of-a-Covid-19-vaccine-bRANDSPURNG.png?fit=1024%2C576&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/12\/Sanofi-and-GSK-suffers-major-setback-in-the-development-of-a-Covid-19-vaccine-bRANDSPURNG.png?fit=1024%2C576&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/12\/Sanofi-and-GSK-suffers-major-setback-in-the-development-of-a-Covid-19-vaccine-bRANDSPURNG.png?fit=1024%2C576&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":96508,"url":"https:\/\/brandspurng.com\/2021\/07\/30\/sanofi-sales-grew-double-digit-to-e8-7-billion\/","url_meta":{"origin":72865,"position":4},"title":"Sanofi Sales Grew Double-Digit To \u20ac8.7 Billion","author":"Brand Spur","date":"July 30, 2021","format":false,"excerpt":"Sanofi Q2 2021 sales grew double-digit to \u20ac8.7 billion (up 12.4% at CER) mainly driven by Dupixent\u00ae\u00a0and Vaccines as indicated in its financial result ended June 30, 2021. Specialty Care sales increased 22.0%, due to strong Dupixent\u00ae\u00a0(+56.6%) and new oncology Vaccines up 16.2%, driven by meningitis and boosters franchise recovery;\u2026","rel":"","context":"In "Brand News"","block_context":{"text":"Brand News","link":"https:\/\/brandspurng.com\/category\/brand-news\/"},"img":{"alt_text":"Sanofi and GSK suffers major setback in the development of a Covid-19 vaccine bRANDSPURNG","src":"https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/12\/Sanofi-and-GSK-suffers-major-setback-in-the-development-of-a-Covid-19-vaccine-bRANDSPURNG.png?fit=1024%2C576&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/12\/Sanofi-and-GSK-suffers-major-setback-in-the-development-of-a-Covid-19-vaccine-bRANDSPURNG.png?fit=1024%2C576&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/12\/Sanofi-and-GSK-suffers-major-setback-in-the-development-of-a-Covid-19-vaccine-bRANDSPURNG.png?fit=1024%2C576&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/12\/Sanofi-and-GSK-suffers-major-setback-in-the-development-of-a-Covid-19-vaccine-bRANDSPURNG.png?fit=1024%2C576&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":93441,"url":"https:\/\/brandspurng.com\/2021\/06\/21\/covid-19-deepens-merchandise-trade-deficit\/","url_meta":{"origin":72865,"position":5},"title":"COVID-19 Deepens Merchandise Trade Deficit","author":"Vetiva Research","date":"June 21, 2021","format":false,"excerpt":"According to the National Bureau of Statistics (NBS), Nigeria recorded higher trade volumes in the first quarter of the year (+7.0% q\/q; +14.1% y\/y). This represents the highest quarterly trade flows (Q1\u201921: \u20a69.8 trillion) Nigeria has recorded since the pandemic disrupted global supply chains (Q1\u201920: \u20a68.5 trillion). While the recovery\u2026","rel":"","context":"In "Business & Economy"","block_context":{"text":"Business & Economy","link":"https:\/\/brandspurng.com\/category\/business-economy\/"},"img":{"alt_text":"Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine","src":"https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/09\/Sanofi-and-GSK-sign-agreements-with-the-Government-of-Canada-to-supply-up-to-72-million-doses-of-adjuvanted-COVID-19-vaccine-Brandspurng.jpg?fit=1200%2C798&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/09\/Sanofi-and-GSK-sign-agreements-with-the-Government-of-Canada-to-supply-up-to-72-million-doses-of-adjuvanted-COVID-19-vaccine-Brandspurng.jpg?fit=1200%2C798&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/09\/Sanofi-and-GSK-sign-agreements-with-the-Government-of-Canada-to-supply-up-to-72-million-doses-of-adjuvanted-COVID-19-vaccine-Brandspurng.jpg?fit=1200%2C798&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/09\/Sanofi-and-GSK-sign-agreements-with-the-Government-of-Canada-to-supply-up-to-72-million-doses-of-adjuvanted-COVID-19-vaccine-Brandspurng.jpg?fit=1200%2C798&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/brandspurng.com\/wp-content\/uploads\/2020\/09\/Sanofi-and-GSK-sign-agreements-with-the-Government-of-Canada-to-supply-up-to-72-million-doses-of-adjuvanted-COVID-19-vaccine-Brandspurng.jpg?fit=1200%2C798&ssl=1&resize=1050%2C600 3x"},"classes":[]}],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/brandspurng.com\/wp-json\/wp\/v2\/posts\/72865"}],"collection":[{"href":"https:\/\/brandspurng.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brandspurng.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brandspurng.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/brandspurng.com\/wp-json\/wp\/v2\/comments?post=72865"}],"version-history":[{"count":0,"href":"https:\/\/brandspurng.com\/wp-json\/wp\/v2\/posts\/72865\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/brandspurng.com\/wp-json\/wp\/v2\/media\/72866"}],"wp:attachment":[{"href":"https:\/\/brandspurng.com\/wp-json\/wp\/v2\/media?parent=72865"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brandspurng.com\/wp-json\/wp\/v2\/categories?post=72865"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brandspurng.com\/wp-json\/wp\/v2\/tags?post=72865"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}